跳至主要内容
临床试验/NCT03922906
NCT03922906终止不适用

Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation

Motus GI Medical Technologies Ltd1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2020年1月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
3
试验地点
1
主要终点
Number of Participants With Boston Bowel Preparation Scale( BBPS) >1 in All Colon Segments After the Use of Pure-Vu System

研究概览

简要总结

The study aim to evaluate the performance of Pure-Vu System in cleansing patients' colon with history of inadequate bowel preparation who are indicated for a colonoscopy procedure.

详细描述

The study is planned as a single arm, open trial will include up to 30 patients, aim to evaluate the performance of Pure-Vu System in cleansing patients' colon with history of inadequate bowel preparation who are indicated for a colonoscopy procedure.

Subjects will be enrolled at up to 3 clinical sites in Israel. Subjects who meet the eligibility criteria will be required to follow a standard bowel preparation instruction. Patients will be asked to record and provide their diet and bowel movements in the provided diary log at time of their scheduled colonoscopy (Diary log is provided in appendix C) and to complete a satisfaction questionnaire include feedback on the procedure and on specific aspects related to the preparation regime.

Following the procedure a telephone follow-up will be conducted at 48 hours (± 48 hours) post Pure-Vu procedure to assess patient well-being and capture any adverse events.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
22 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Subjects with history of inadequate bowel preparation.
  • •Subjects in the age range of 22-75 years inclusive
  • •Subjects with BodyMass Index (BMI) within the range of 18.5-35 inclusive
  • •Subject has signed the informed consent

排除标准

  • •Patients with active Inflammatory Bowel Disease
  • •Patients with previous history of acute diverticulitis disease or with prior incomplete colonoscopy due to diverticular disease
  • •Patients with known bowel obstruction / strictures
  • •History of prior surgery to colon and/or rectum
  • •Renal insufficiency (Creatinine ≥ 1.5mg /dL) (based on medical history)
  • •Abnormal Liver enzymes (ALT/AST ≥ 2 times upper limits of normal) (based on medical history)
  • •Patients taking anticoagulants drugs (excluding aspirin) or dual antiplatelet therapy
  • •Patients with known coagulation disorder (INR >1.5).
  • •Patients at risk of hypokalemia or hyponatremia
  • •Patients with congestive cardiac failure
  • •Pregnancy (as stated by patient) or breast feeding
  • •Patients with altered mental status/inability to provide informed consent
  • •Patients who have participated in another interventional clinical study in the last 2 months

研究组 & 干预措施

Motus Pure-Vu System

Experimental

The Pure-Vu System enables colon cleansing during standard colonoscopy using a standard colonoscope. The cleansing device, which is attached to the tip of the colonoscope and is connected to an external workstation, generates fluid jets within the colon thus dissolving the feces into small parts. The fecal matter & fluids are drained through the evacuation pipe of the cleansing device into a collecting reservoir.

干预措施: Pure-Vu System (Device)

结局指标

主要结局

Number of Participants With Boston Bowel Preparation Scale( BBPS) >1 in All Colon Segments After the Use of Pure-Vu System

时间窗: Up to 2 hours

The rating of the cleansing quality was evaluated by using the Boston Bowel Preparation Scale (BBPS), Segment score of 0-3 given to each of the 3 segments of the colon (Left side, Transverse and right side): Score 0- Unprepared colon segment with mucosa not seen due to solid stool that cannot be cleared. Score 1- A portion of the mucosa of the colon segment is seen, but other areas of the colon segment are not seen well due to staining, residual stool, and/or opaque liquid. Score 2- A minor amount of residual staining, small fragments of stool, and/or opaque liquid are visible, but the mucosa of the colon segment are seen well. Score 3-The entire mucosa of the colon segment is seen well with no residual staining, small fragments of stool, or opaque liquid. subject consider as having adequate cleaning if BBPS\>1 in all colon segments

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验